CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 21,400 full-time employees. The firm operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The firm conducts its business in the domestic and overseas markets.
根据最新的财务报表(Form-10K),CSPC Pharmaceutical Group Limited 的总资产为 $0,净损失为 $0
CSPCY 的关键财务比率是什么?
CSPC Pharmaceutical Group Limited 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
CSPC Pharmaceutical Group Limited 的收入按细分市场或地理位置如何划分?
CSPC Pharmaceutical Group Limited 最大收入来源是 Total Finished Drugs,在最近的收益报告中收入为 17,937,001,000。就地区而言, Mainland China 是 CSPC Pharmaceutical Group Limited 的主要市场,收入为 25,106,726,000。
CSPC Pharmaceutical Group Limited 是否盈利?
不,根据最新的财务报表,CSPC Pharmaceutical Group Limited 的净损失为 $0